404
Transforming Growth Factor Beta 1 Market Report
Global Transforming Growth Factor-Beta 1 Market, Dynamics, and Market Analysis
The transforming growth factor beta 1 market size is expected to reach USD 2.0 billion in the foreseeable future.
F. Hoffmann-La Roche AG (Switzerland), Shionogi & Company, Limited (Japan), Isarna Holding GmbH (Germany), Scholar Rock Holding (The U.S), Acceleron Pharma, Inc. (The U.S), Sanofi Genzyme (The U.S), Sirnaomics, Inc. (The U.S), Eli Lilly and Company (The U.S), Novartis International AG (Switzerland) and Formation Biologics Inc. (The U.S) are among the key players in the transforming growth factor beta 1 market.
The transforming growth factor beta 1 market is expected to witness an impressive growth of 11.1% CAGR in the coming years.
Europe accounted for the largest share of transforming growth factor beta 1 market in 2020.
The idiopathic pulmonary fibrosis segment is expected to register higher CAGR in the transforming growth factor beta 1 market in the coming years.
Increasing usage in treating diseases such as cancer and idiopathic pulmonary fibrosis, increasing number of people suffering from various cancers, Growing emphasis on investment in R&D activities are the factors driving the growth of transforming growth factor beta 1 market.
Transforming growth factor beta 1 manufacturers, Transforming growth factor beta 1 suppliers, Transforming growth factor beta 1 distributors, Organizations, Government bodies are the target audience in the transforming growth factor beta 1 market.